Upcoming Virtual Event A Paradigm Shift in Infectious Diseases: Lessons from a Pandemic
Merck, a leading global science and technology company, prides itself in working to solve the toughest problems in life science by collaborating with the global scientific community. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases – including cancer and infectious diseases such as HIV and Ebola, Merck aims to accelerate access to better health for people everywhere. Merck will be hosting an upcoming two-day virtual event, A Paradigm Shift in Infectious Diseases: Lessons from a Pandemic. Scheduled to take place September 1-2, this gathering is being organized across the Asia Pacific region. The event will provide a platform for the scientific community to share research and insights, and provide a discourse on the topic of infectious disease and immunity.
A Paradigm Shift in Infections Diseases: Lessons from a Pandemic will focus on four main themes:
- Science of Infectious Disease
- Economics of Disease Control and Considerations for Public Health
- Diagnosis & Innovation during a Pandemic
- Vaccine Development & Therapeutics
Esteemed speakers from these fields will be presenting their latest research, and you are encouraged to interact and have your questions answered during the Q&A and panel sessions.
A Paradigm Shift in Infectious Diseases: Lessons from a Pandemic is free to attend and will remain open throughout 2020. For more information about the event, speakers, and how to register, click here.
Merck, a leading science and technology company, operates across healthcare, life science and performance materials. Around 52,000 employees work to make a difference in people’s lives daily by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices, the company is everywhere.
Merck holds the global rights to the Merck name and brand. The exceptions are the United States and Canada, where the business sectors of Merck operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Performance Materials.
LabRoots is the leading scientific social networking website, offering top scientific trending news and premier educational virtual events and webinars. Contributing to the advancement of science through content sharing capabilities, LabRoots is a powerful advocate in amplifying global networks and communities. Not registered yet as a LabRoots user? Click here to sign up for free.